1 s2.0 S2405587515300263 Main
1 s2.0 S2405587515300263 Main
1 s2.0 S2405587515300263 Main
Center of Cardiology and Exercise Medicine, Center of Health Science, and Sports CEFID, Santa Catarina State University UDESC, Brazil
Research Group of Cardiovascular and Respiratory Rehabilitation, Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven, Leuven, Belgium
a r t i c l e
i n f o
Article history:
Received 16 September 2015
Received in revised form 17 November 2015
Accepted 22 November 2015
Available online 23 November 2015
Keywords:
Heart failure
Rehabilitation
Intensity training
Life style
Health status
a b s t r a c t
Purpose: To compare the effect of high intensity interval training (HIIT) and moderate intensity continuous
training (MICT) on physical tness and quality of life (QoL) in patients with chronic heart failure (CHF).
Methods: Twenty-two male CHF patients (LVEF b 45%, mean age 53.8 8 yr) were studied before and after
12 weeks of supervised aerobic training for 60 min, three times a week. Patients were randomly (1:1) to MICT
(n = 10) and HIIT (n = 12). Both training programs involved treadmill exercise. The group MICT at 75%
of peak heart rate (HR) and HIIT at 95% of peak HR. Outcome measurements included an assessment of QoL
(Minnesota Living with Heart Failure Questionnaire (MLHFQ) and SF-36), measurements of 6-min walk test
(6MWT) and peak oxygen consumption (VO2 peak).
Results: Exercise was associated with a signicant increased of 6MWT in 19.4% and 23.1% from MCIT and HIIT,
respectively (p b 0.001), but not between-group differences. It was observed an improvement in VO2 peak by
11.2% in the HIIT group and 8.3% in the MCIT group, with between-group differences (p b 0.01). Quality of life
improved signicantly and in all domains in both groups (p-value time-effect). All patients showed signicant
improvements in all domains from baseline, it was observed in both groups (p b 0.05), with between-group
differences for functional capacity (SF-36). No changes were observed in pain (SF-36) for both groups.
Conclusion: Both training programs were equally effective in improving QoL and functional capacity in
CHF patients.
Trial registration: (http://www.ensaiosclinicos.gov.br/): RBR-6hk9p6; registered on 15 May 2013.
2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Up to ve million Americans over 20 years old have chronic heart
failure (CHF). Projections show that by 2030, the prevalence of CHF
will increase with 25% from 2013 [1]. CHF is a complex chronic condition
that results from any structural or functional impairment of ventricular
lling or ejection of blood [2]. One of the major central characteristics
of this condition is an imbalance of the cardiovascular system caused
by complex hemodynamic, anatomical, functional and biological
progressively worsening, thus creating a vicious cycle [3,4].
As a result, most heart failure patients experience symptoms as
shortness of breath and fatigue, which interfere with daily activities
All authors take responsibility for all aspects of the reliability and freedom from bias of
the data presented and their discussed interpretation.
Corresponding author at: Pascoal Simone Street, 358 Coqueiros, Florianopolis,
SC 88080-350, Brazil.
E-mail address: anderon_u@hotmail.com (A.Z. Ulbrich).
and often have a tremendous impact on the quality of life (QoL) [5,6].
The quality of life is much lower compared to healthy individuals and
other diseases [7]. Current guidelines for the treatment and management of heart failure rmly recommend regular physical activity and
structured exercise training [8]. The major benets of this multidisciplinary approach include an enhancement in peripheral blood circulation [9], as well as in skeletal muscle and functional capacity [1013],
early return to routine, increased aerobic conditioning and signicant
benets in social life [14,15]. Moreover, exercise training, as an important adjuvant part of this rehabilitation program, has been shown to improve endothelial function and oxidative capacity of the skeletal muscle
[16,17], increase of peak oxygen consumption [16,18,19] and maximal
aerobic power and reduce neurohumoral exacerbation [12,15].
However, despite its proven effectiveness, the search for better
exercise modalities that t patients' taste better and are more likely to
improve adherence and hence clinical outcomes in heart failure patients
is still ongoing. As such, recent data have already shown that high intensity interval training is superior to moderate continuous training for
http://dx.doi.org/10.1016/j.ctrsc.2015.11.005
2405-5875/ 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
22
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
2. Methods
2.1. Study design and population
A randomized controlled double-blind trial was performed to
evaluate the effect of HIIT vs MICT on quality of life and physical tness
in CHF patients. Patients were recruited at the Divisions of Cardiology of
the public and private hospitals of Florianopolis, Santa Catarina State,
Brazil. Eligibility criteria were that participants should be: 1) male;
2) aged 40 yr or older; 3) with a resting left ventricular ejection fraction
under 40%; 4) peak oxygen uptake under 20 mlkgmin; 5) classied as
New York Heart Association class (NYHA) IIIII who were clinically
stable and on optimal medical therapy for at least 30 days. In addition,
they should be free of physical or mental disabilities, which could
limit physical training. Patients were excluded if they presented with
unstable angina pectoris, uncompensated heart failure, primary pulmonary hypertension, pulmonary infections or active pulmonary thromboembolism, myocardial infarction in the past 4 weeks and complex
ventricular arrhythmias.
After obtaining written informed consent patients were randomized
to HIIT or MICT. The randomization code was generated by means of a
simple allotment to select random permuted blocks (Fig. 1).
The study was accomplished according to the World Medical
1975 Declaration of Helsinki on ethics in medical research [24]
and was approved by the local Research Ethics Committee of the
University of the State of Santa Catarina. The design and results
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
23
24
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
Table 1
Baseline descriptive characteristics of CHF patients.
MCIT
(n = 10)
HIIT
(n = 12)
p-Value
Age (years)
Weight (kg)
Height (cm)
BMI (kg/m2)
54.02 9.9
81.03 19.9
170.73 17.1
27.47 4.6
53.15 7.0
85.4 17.1
169.3 8.8
29.73 5.4
0.231
0.543
0.415
1.047
0.820
0.593
0.683
0.307
Hemodynamics
Resting SBP (mm Hg)
Resting DBP (mm Hg)
Resting HR (beats/min)
113.63 14.3
73.9 9.3
88.25 24.9
130.00 25.5
79.3 12.8
84.80 24.19
1.834
1.104
0.327
0.082
0.284
0.747
11 (50%)
1 (4.5%)
10 (45.5%)
-
0.873
0.350
8 (36.4%)
4 (18.2%)
7 (31.8%)
3 (13.6%)
0.028
0.867
1 (4.5%)
6 (27.6%)
5 (22.7%)
11 (50%)
0 (0%)
5 (22.7%)
5 (22.7%)
7 (31.8%)
0.917
0.632
1.721
0.190
9 (40.9%)
8 (36.4%)
0.078
0.781
7 (31.8%)
6 (27.3%)
1 (4.5%)
4 (18.2%)
5 (22.7%)
3 (13.6%)
5 (22.7%)
8 (36.4%)
2 (9.1%)
2 (9.1%)
7 (31.8%)
3 (13.6%)
5 (22.7%)
0.153
2.121
2.640
0.630
2.933
1.497
1.744
0.696
0.145
0.104
0.427
0.087
0.473
0.4367
11 (50%)
10 (45.5%)
7 (38.8%)
11 (50%)
3 (13.6%)
9 (40.9%)
2 (9.1%)
4 (18.2%)
32.8 7.7
18.39 4.3
447.4 60.3
8 (36.4%)
10 (45.5%)
5 (22.7%)
9 (40.9%)
3 (13.6%)
5 (22.7%)
1 (4.5%)
7 (31.8%)
35.40 6.7
21.41 4.1
456.6 36.3
0.630
1.833
0.153
0.018
0.069
1.473
0.206
2.933
0.793
0.908
0.343
0.427
0.176
0.696
0.892
0.793
0.225
0.650
0.087
0.439
0.375
0.735
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
25
Table 2
Baseline and changes in hemodynamics, functional capacity, and quality of life (MLHFQ and SF-36) after 12 weeks of training.
MCIT
(n = 10)
HIIT
(n = 12)
Baseline
12 weeks follow-up
Baseline
12 weeks follow-up
Hemodynamics
Resting SBP (mm Hg)
Resting DBP (mm Hg)
Resting HR (beats/min)
LVEF (%)
113.1 13.7
73.7 8.9
84.7 12.8
32.8 7.7
105.0 12.5
68.7 8.5
71.8 11.6
35.7 11.3
8.2
8.1
19.6
8.12
0.065
0.108
0.007
0.369
130.0 25.5
79.3 12.8
83.1 19.1
35.4 6.4
111.4 15.5
71.9 8.0
75.4 10.4
39.9 8.8
16.3
10.3
12.0
9.7
Functional capacity
VO2 peak (mlkg1min1)
6MWT (m)
18.39 4.3
464.0 60.3
20.23 3.0
557.9 56.9
8.3%
19.4%
0.041
b0.001
21.41 4.1
456.6 36.3
24.2 4.6,
596.3 48.5
11.2%
23.1%
MLHFQ
Physical dimension
Emotional dimension
Reminiscent questions
Total scale score
13.9 6.9
9.4 4.6
15.7 3.9
39.1 12.1
8.4 5.9
4.7 3.6
8.1 5.0
20.8 11.6
110%
320%
246%
156%
0.012
0.034
0.008
b0.001
12.3 9.9
8.5 7.1
12.8 6.2
33.5 17.4
7.8 6.7
5.1 4.4
6.8 5.0
18.9 14.7
120%
207%
266%
289%
SF-36
Physical functioning
Role-physical
Bodily pain
General Health
Vitality
Social functioning
Role-emotional
Mental health
54.5 18.6
16.6 22.1
62.1 18.2
5.0 4.7
50.8 20.5
56.2 18.1
61.1 23.0
66.0 25.3
74.1 16.8
78.1 23.9
65.5 15.6
13.2 5.7
70.4 14.5
94.7 9.9
90.6 20.5
81.3 19.1
29.2%
80.1%
1.7%
53.8%
26.5%
40.8%
23.5%
18.6%
0.020
b0.001
0.557
0.010
0.015
0.001
0.012
0.033
69.0 18.2
20.0 28.3
53.9 19.9
8.5 6.8
57.5 22.6
67.5 25.1
79.4 18.1
69.8 239
89.5 7.6,
75.0 23.5
57.7 15.6
14.9 3.0
78.5 14.7
90.0 14.9
96.6 10.5
81.2 17.3
23.2%
77.5%
2.9%
47.1%
26.5%
26.7%
18.1%
16.6%
p-Value
p-Value
p-Value
0.004
0.049
0.295
0.013
0.305
0.386
0.463
0.315
b0.001
b0.001
0.003
0.954
0.027
0.017
0.010
0.005
0.967
0.767
0.590
0.826
0.009
b0.001
0.613
0.007
0.008
0.002
0.005
0.002
0.025
0.543
0.220
0.642
0.668
0.500
0.114
0.787
SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; LVEF: left ventricular ejection fraction; VO2 peak: peak of oxygen uptake; 6MWT: six minutes walk test; MLHFQ:
Minnesota Living with Heart Failure Questionnaire; SF-36: Long Form 36 Health Survey; WRpeak: limit of tolerance. Footnotes indicate signicant changes. Values in mean SD.
From baseline to 12 weeks (p b 0.05) within groups.
From 12 weeks to 12 weeks (p b 0.05) between groups.
which might explain the major ndings in our study. Morgan et al. [5] also
in a systematic review emphasized the innovation of CHF treatment by
means of primary and secondary interventions, in order to maintain and
improve the clinical conditions associated with QoL of these patients, decreasing dyspnea, fatigue, and palpitations that these patients feel to perform daily activities. So, the exercise is also recognized in full cardiac
Fig. 2. Quality of life (MLHFQ) evaluated by the multiple domain questionnaires both before and after 12 weeks of exercise training. Signicant differences between the moments (before vs
after) (p b 0.05). (p b 0.05) Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-interval intensity training.
26
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
Fig. 3. Quality of life (SF-36) evaluated by the multiple domain questionnaires both before and after 12 weeks of exercise training. Signicant differences between the moments (before vs
after) (p b 0.05). (p b 0.05) Abbreviations: MICT: moderate-intensity continuous training; HIIT: high-interval intensity training.
rehabilitation in heart failure [8]. Carvalho et al. [59] ensure that the best
physical, psychological and social conditions, as seen in this study with
increasing CF and QoL and after intervention. Corroborating, Belardinelli
et al. [60] using the MLWHFQ and Gianuzzi et al. [61], the modied Likert
instrument, show an improvement in QoL in CHF patients associated
with exercise capacity and clinical improvement [62]. On the other
hand, studies were able to demonstrate improvement in QoL without
necessarily having an increase in exercise tolerance [63,64], or even a
weak association between these two variables [43,65]. With reduced
physical symptoms through exercise seen in the present study, no such
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
27
28
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 2128
on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
Circulation 2002;106(14):188392.
Beevers G, Lip GY, O'Brien E. ABC of hypertension: blood pressure measurement.
Part II-conventional sphygmomanometry: technique of auscultatory blood pressure
measurement. BMJ 2001;322(7293):10437.
Mezzani A, Agostoni P, Cohen-Solal A, Corra U, Jegier A, Kouidi E, et al. Standards for
the use of cardiopulmonary exercise testing for the functional evaluation of cardiac
patients: a report from the Exercise Physiology Section of the European Association
for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil
2009;16(3):24967.
American Thoracic S. American College of Chest P. ATS/ACCP Statement on
cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2):21177.
Borg E, Kaijser L. A comparison between three rating scales for perceived exertion
and two different work tests. Scand J Med Sci Sports 2006;16(1):5769.
Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al.
Recommendations for the evaluation of left ventricular diastolic function by
echocardiography. Eur J Echocardiogr 2009;10(2):16593.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.
Recommendations for chamber quantication: a report from the American Society
of Echocardiography's Guidelines and Standards Committee and the Chamber
Quantication Writing Group, developed in conjunction with the European
Association of Echocardiography, a branch of the European Society of Cardiology.
J Am Soc Echocardiogr 2005;18(12):144063.
Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living
with Heart Failure questionnaire: reliability and validity during a randomized,
double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter
Research Group. Am Heart J 1992;124(4):101725.
Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health
survey questionnaire: an outcome measure suitable for routine use within the
NHS? BMJ 1993;306(6890):14404.
Carvalho VO, Guimaraes GV, Carrara D, Bacal F, Bocchi EA. Validation of the
Portuguese version of the Minnesota Living with Heart Failure Questionnaire. Arq
Bras Cardiol 2009;93(1):3944.
Campolina AG, Ciconelli RM. SF-36 and the development of new assessment tools
for quality of life. Acta Reumatol Port 2008;33(2):12733.
Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al.
Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;
115(24):308694.
Muller-Nordhorn J, Kulig M, Binting S, Voller H, Gohlke H, Linde K, et al. Change in
quality of life in the year following cardiac rehabilitation. Qual Life Res 2004;
13(2):399410.
Quittan M, Sturm B, Wiesinger GF, Pacher R, Fialka-Moser V. Quality of life in
patients with chronic heart failure: a randomized controlled trial of changes induced
by a regular exercise program. Scand J Rehabil Med 1999;31(4):2238.
Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is the real polypill.
Physiology (Bethesda) 2013;28(5):33058.
Nobre F. Introduction: Brazilian guidelines on hypertension VI. Brazilian Society of
Cardiology, Brazilian Society of Hypertension, Brazilian Society of Nephrology.
J Bras Nefrol 2010;32(Suppl. 1):III.
Bocchi EA, Braga FG, Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, et al.
III Brazilian Guidelines on chronic heart failure. Arq Bras Cardiol 2009;
93(1 Suppl. 1):370.
Fletcher GF, Ades PA, Kligeld P, Arena R, Balady GJ, Bittner VA, et al. Exercise
standards for testing and training: a scientic statement from the American Heart
Association. Circulation 2013;128(8):873934.
Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation
during exercise in patients with chronic cardiac failure. Circulation 1982;65(6):
121323.
Piepoli MF, Davos C, Francis DP, Coats AJ, ExTra MC. Exercise training metaanalysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ
2004;328(7433):189.